Delivery Order SPE2DB22D6029-SPE2DB25FLVRC
- Not listed
- The Defense Logistics Agency awarded a $2,587.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lupron Depot-Ped 11.25 mg kits, with an ultimate completion date of August 6, 2025. This non-set-aside award reflects a competitively awarded transaction for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through...
- The Defense Logistics Agency awarded a $23,165.02 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Lupron Depot-Ped 11.25 mg kits. The contract is unclassified as a set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency Medical Supply Chain awarded a $42,779.28 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits, with final delivery required by July 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $17,899.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lupron Depot 3.75 mg kits, with an ultimate completion date of July 22, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $33,553.93 to AmerisourceBergen Drug Corp for Lupron Depot-Ped 30 mg 3-month kits, a specialty pharmaceutical product used in pediatric endocrinology treatment. This firm fixed-price delivery order, awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $9,014.39 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 3.75 mg kits. This competitively awarded, firm fixed-price contract has an ultimate completion date of July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Lupron Depot is a leuprolide acetate-based pharmaceutical product used in hormonal therapies, and this order represents a single delivery transaction under the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,385.87, is for the delivery of LUPRON DEPOT-PED 11.25 MG KITS, a specialty medication. The contract is a Firm Fixed Price (FFP) type with a completion date of January 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lupron Depot 3.75 mg kits, valued at $15,025.58 under a firm fixed-price contract type. The order, which has an ultimate completion date of July 29, 2025, represents a non-set-aside award and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,029,817 units of LUPRON DEPOT-PED 7.5 MG KITS. The firm fixed price contract, valued at $1,677.47, has a period of performance through March 21, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 31,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lupron Depot-Ped 15 mg kits. The $11,029.35 firm fixed-price contract has an ultimate completion date of December 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which covers a comprehensive...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB25FLVRCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,632.97 to AmerisourceBergen Drug Corp for the supply of Lupron Depot-PED 7.5 mg kits under a firm fixed price contract. The award, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a competitively awarded non-set-aside procurement. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contracts with DLA and the Medical Supply Chain, supplying a broad range of pharmaceuticals including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Lupron Depot-PED, a pediatric formulation used in endocrinology treatment, exemplifies the company's capability to fulfill specialized pharmaceutical requirements for the Defense Health Agency and other government healthcare systems through its prime indefinite delivery vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 8/1/25 |